Newsletter Subject

Daily Headlines: RA: Switching to Tocilizumab OK When DMARDs Not Tolerated

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, Oct 10, 2016 11:08 AM

Email Preheader Text

Daily Headlines October 10, 2016 [Source: Robert Michael Educational Institute LLC ] [rnSource: Robe

Daily Headlines October 10, 2016 [RA: Switching to Tocilizumab OK When DMARDs Not Tolerated] [PodMed: A Medical News Roundup From Johns Hopkins] [Child Sepsis App Has Potential, But Lacks Good Instructions] [Tweet of the Week: A REAL Scary Halloween Costume] [Allopurinol Lessens MI Risk in Older Adults] CME/CE Additional Resources [Diagnosis and Treatment of Relapsed Myeloma] [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy] [Boosting Lung Cancer Outcomes in Diabetics] Recent Headlines [Slow Medicine: Sayonara to Sulfonylureas?] [This Week in Zika: Clinical and Public Health Updates] [How Your Gut Instinct Can Steer You Wrong] [Cath Lab Recap: Portable Coagulation Analyzer; Prophylactic IABP Not $$$] [Who Gets Your Vote?] ADVERTISEMENT This Week's Survey [Who Gets Your Vote?] [The election is now just a month away. Who do you plan to vote for?] CME Spotlights [Managing Difficult Communication: The Importance of Non-Verbal Communication] [Source: The University of Texas MD Anderson Cancer Center] [Managing the Patient with Metastatic Melanoma: A Comprehensive, Evidence-Based Approach] [Source: Robert Michael Educational Institute LLC (RMEI)] [Immuno Oncology] [rnSource: @Point of Care] [Clinical Convergenceu2120: Patient and Provider Perspectives in NSCLC: Initial Visits] [rnSource: Robert Michael Educational Institute LLC (RMEI)] [Clinical Convergenceu2120: Patient and Provider Perspectives in NSCLC: Follow-up Visits] [rnSource: Robert Michael Educational Institute LLC (RMEI)] [Biosimilars--Can you explain extrapolation? Interchangeability? Substitution?] [Source: France Foundation] [Playing The Offense In Advanced Basal Cell Carcinoma: A Team Approach To Treatment And Management] [Source: RMEI] [Breast Cancer@POC w/Watson] [Source: Projects in Knowledge, Inc.] More of Today's Stories [Headache Tied to Hypothyroid Risk] CME/CE [CMS Head Reviews Achievements, Talks Agency's Future] [D.C. Week: Insurers Look for Reforms to Stabilize Fragile Markets] [Election 2016: Obamacare Back on Debate Stage] [5 Things to Know About Drug Diversion] [PARP Inhibitor Broadly Active in Ovarian Cancer] [Phantom Phone Sensations: That's Improbable!] [Anti-CDK4/6 Boosts PFS in Metastatic Breast Cancer] More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. © 2016 Medpage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the [MedPageToday.com] [terms of use] and [privacy policy]. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Medpage Today is located at 345 Hudson Street, New York, NY 10014 [Remove me from this list] [Manage my e-mail settings]

Marketing emails from medpagetoday.com

View More
Sent On

08/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

07/06/2024

Sent On

06/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.